CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

  • Michael Pfreundschuh
  • , Lorenz Trümper
  • , Anders Österborg
  • , Ruth Pettengell
  • , Marek Trneny
  • , Kevin Imrie
  • , David Ma
  • , Devinder Gill
  • , Jan Walewski
  • , Pier Luigi Zinzani
  • , Rolf Stahel
  • , Stein Kvaloy
  • , Ofer Shpilberg
  • , Ulrich Jaeger
  • , Mads Hansen
  • , Tuula Lehtinen
  • , Armando López-Guillermo
  • , Claudia Corrado
  • , Adriana Scheliga
  • , Noel Milpied
    • Myriam Mendila, Michelle Rashford, Evelyn Kuhnt, Markus Loeffler

Research output: Contribution to journal › Article › peer-review

1886 Scopus citations

Fingerprint

Dive into the research topics of 'CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry